People: Osteotech Inc (OSTE.O)

OSTE.O on Consolidated Issue listed on NASDAQ Global Market

3.20USD
9 Feb 2010
Price Change (% chg)

$-0.11 (-3.32%)
Prev Close
$3.20
Open
--
Day's High
$3.36
Day's Low
$3.20
Volume
29,743
Avg. Vol
55,345
52-wk High
$5.04
52-wk Low
$2.43

view people for:

Summary

Name Age Since Current Position
Fallon, Kenneth 70 2005 Chairman of the Board
Owusu-Akyaw, Sam 56 2006 President, Chief Executive Officer, Director
Burroughs, Mark 48 2006 Chief Financial Officer, Executive Vice President
Wynalek, Robert 49 2006 President - Domestic
Honneffer, Robert 57 2009 Executive Vice President - Global Operations
Galliker, Stephen 62 2004 Director
Palmisano, Robert 64 2005 Director
Shannon, James 57 2007 Director
Laurencin, Cato 50 2008 Independent Director
» Insider Trading

Biographies

Name Description
Fallon, Kenneth Mr. Kenneth P. Fallon, III is Chairman of the Board of Osteotech Inc. He is Director of Osteotech since June 1995, and as Chairman of the Board since November 2005. Since March 2004, Mr. Fallon has been an Associate with Kairos Partners, an investment firm and a stockholder that owns approximately 8.7% of the Company’s outstanding stock. Mr. Fallon retired as the Chairman of the Board of Axya Medical, Inc., a Massachusetts based privately held medical device company, in March 2003 and was the Chief Executive Officer of Axya Medical Inc., from May 1999 until December 2002. In 1997 and 1998, Mr. Fallon was President of the surgical business at Haemonetics Corporation. In 1994 and 1995, Mr. Fallon served as Chief Executive Officer and Chairman of the Board of UltraCision, Inc., a developer and manufacturer of ultrasonically powered surgical instruments. UltraCision, Inc. was sold to Ethicon EndoSurgery, a unit of Johnson & Johnson, Inc., in November 1995. From 1992 through 1994, Mr. Fallon served as President and Chief Executive Officer of American Surgical Technologies Corporation. Mr. Fallon was President, U.S. Operations of Zimmer, Inc., then a subsidiary of Bristol-Myers Squibb Company, from 1991 to 1992. From 1985 through 1991 he served as President of Zimmer’s Orthopaedic Implant Division, and from 1983 to 1985 as its Vice President of Marketing. Mr. Fallon previously served in positions of significant responsibility with the Codman and Orthopedic Divisions of Johnson & Johnson, Inc. Mr. Fallon is also a director of Conformis Inc., a privately held medical device firm. Mr. Fallon has a B.B.A. degree in marketing from the University of Massachusetts and an M.B.A. from Northeastern University.
Owusu-Akyaw, Sam Mr. Sam Owusu-Akyaw is President, Chief Executive Officer, Director of Osteotech Inc Since January 2006, he has served in his current position of President, Chief Executive Officer and Director. Prior to joining Osteotech, Mr. Owusu-Akyaw served as General Manager of Medtronic Midas Rex and Vice President of Medtronic, Inc. from 2000 through June 2004, and Chief Operating Officer of Medtronic Midas Rex from 1999 to 2000. Mr. Owusu-Akyaw was Vice President of Operations of DePuy-Acromed, a Johnson & Johnson Company, from 1998 to 1999 and Vice President of Acromed, Inc. from 1996 to 1998. Mr. Owusu-Akyaw was Vice President, BMS Productivity for Growth Initiative of Bristol-Myers Squibb Company from 1994 to 1996. From 1977 to 1994, Mr. Owusu-Akyaw served in positions of increasing responsibility with Zimmer, Inc., then a subsidiary of Bristol-Myers Squibb Company. Mr. Owusu-Akyaw has a B.A. degree in accounting and computer science from Manchester College and an M.B.A. in finance and operations from the University of Houston.
Burroughs, Mark Mr. Mark H. Burroughs is Executive Vice President and Chief Financial Officer since January 2006. Mr. Burroughs joined Osteotech in November 2000 as Vice President Finance and Treasurer. Prior to joining Osteotech, Mr. Burroughs was Senior Vice President, Finance for MEDIQ/PRN Life Support Services, Inc. During his eight-year tenure with MEDIQ/PRN, from November 1992 to October 2000, Mr. Burroughs served in a variety of executive level capacities in finance, operations, business development and mergers and acquisitions. Previously, Mr. Burroughs held positions of increasing responsibility for nine years with Deloitte & Touche. Mr. Burroughs is a Certified Public Accountant and has a B.S. in Accounting from Montclair State University.
Wynalek, Robert Mr. Robert M. Wynalek is President Domestic since April 2006. From September 2004 to April 2006, Mr. Wynalek served as Senior Vice President, Sales & Marketing. Prior to joining Osteotech, Mr. Wynalek had more than 23 years sales and marketing experience in the medical device and related industries. Mr. Wynalek served as Vice President of Marketing for Medtronic Powered Surgical Solutions from April 1999 to September 2004, and as Director, Powered Surgical Systems, a division of Medtronic Sofamor Danek, from June 1996 until April 1999. From September 1990 until June 1996, Mr. Wynalek served in positions of increasing responsibility with Smith & Nephew Orthopedics. From June 1981 until September 1990, Mr. Wynalek held positions with Becton Dickinson and Company and Levor Brothers Company. Mr. Wynalek has a B.S.B.A. in Marketing from Bowling Green University.
Honneffer, Robert Mr. Robert W. Honneffer is Executive Vice President - Global Operations of Osteotech Inc since January 2009. He joined Osteotech in September 2004. From April 2006 to January 2009, Mr. Honneffer served as Senior Vice President, Operations. From December 2004 to April 2006, Mr. Honneffer served as Vice President Operations and, from September 2004 to December 2004, he served as Vice President Supply Chain & Distribution. Mr. Honneffer has over 30 years of diversified medical device experience. Immediately prior to joining Osteotech, Mr. Honneffer served as Director of Customer Services and Technical Support at Medtronic Powered Surgical Solutions from June 2002 to September 2004. Prior to joining Medtronic, Mr. Honneffer held positions in business development and general management with CASurgica Inc., OrtoMaquet AG, and Unique Instruments Inc. From 1973 until 1997, Mr. Honneffer held various positions of increasing responsibility with Zimmer, Inc., then a division of Bristol-Myers Squibb Inc. Mr. Honneffer has an M.S. in Business Administration from St. Francis College and a B.S. in Mechanical Engineering from Youngstown State University.
Galliker, Stephen Mr. Stephen S. Galliker is Director of Osteotech Inc since March 2004. Since September 1999, Mr. Galliker has served as Executive Vice President, Finance and Administration, and Chief Financial Officer of Dyax Corp., a biopharmaceutical company. He was Chief Financial Officer of Excel Switching Corporation, a developer and manufacturer of open switching platforms for telecommunications networks, from July 1996 to September 1999, and was Excel’s Vice President, Finance and Administration from September 1997 to September 1999. Mr. Galliker was employed by UltraCision, Inc., a developer and manufacturer of ultrasonically powered surgical instruments from September 1992 to June 1996. At UltraCision, Inc., Mr. Galliker was Chief Financial Officer and Vice President of Finance until November 1995 and Chief Operating Officer from December 1995 to June 1996. In addition, Mr. Galliker has been a director of RXi Pharmaceuticals, a publicly held biopharmaceutical company, since 2007. Mr. Galliker has a B.S.B.A. in management and finance from Georgetown University and an M.B.A. from the University of Chicago.
Palmisano, Robert Mr. Robert J. Palmisano is Director of Osteotech Inc since March 2005. Mr. Palmisano is currently the President and Chief Executive Officer of ev3, Inc., a medical device company focused on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. From November 2007 until April 2008, Mr. Palmisano was a venture partner with SV Life Sciences in Boston, Massachussets. From April 2003 until April 2008, Mr. Palmisano was the President, Chief Executive Officer and a director of IntraLase Corp., a company engaged in the design, development and manufacture of laser products for vision correction, which was acquired by Advanced Medical Optics, Inc. in April 2007. Prior to joining IntraLase, from April 2001 to April 2003, Mr. Palmisano was the President, Chief Executive Officer and a director of MacroChem Corporation, a development stage pharmaceutical corporation. From April 1997 to January 2001, Mr. Palmisano served as President and Chief Executive Officer and a director of Summit Autonomous, Inc., a global medical products company that was acquired by Alcon, Inc. in October 2000. Prior to 1997, Mr. Palmisano held various executive positions with Bausch & Lomb Incorporated, a global eye care company. In addition, Mr. Palmisano has been a director of OraMetrix, Inc. since October 2005 and ev3, Inc. since April 2008. Mr. Palmisano has a B.A. degree in Political Science from Providence College.
Shannon, James Mr. James M. Shannon is Director of Osteotech Inc since March 2007. Since June 2002, Mr. Shannon has been the President and Chief Executive Officer of the National Fire Protection Association (the “NFPA”), an international organization which is the world’s advocate for fire prevention, providing and developing codes and standards, research, training and education. From 1991 until June 2002, he was Senior Vice President and General Counsel of NFPA. Formerly, Mr. Shannon was the Attorney General of the Commonwealth of Massachusetts from 1987 to 1991 and a Senior Partner at the law firm of Hale & Dorr from 1985 to 1987. From 1979 to 1985, Mr. Shannon represented the Commonwealth of Massachusetts in the U.S. House of Representatives, where he served as a member of the Ways and Means Committee for six years and served on the Trade, Health and Social Security Subcommittees. Mr. Shannon has a B.A. degree from Johns Hopkins University and a J.D. from George Washington University.
Laurencin, Cato Dr. Cato T. Laurencin is Director of Osteotech, Inc effective September 24, 2008. He serves on the Audit and the Compensation Committees of the Board of Directors. Dr. Laurencin is currently the Vice President for Health Affairs at the University of Connecticut Health Center and Dean of the University of Connecticut School of Medicine. At the University of Connecticut, Dr. Laurencin also holds the Albert and Wilda Van Dusen Endowed Chair in Academic Medicine and is a Distinguished Professor of Orthopaedic Surgery. From February 2003 until August 2008, Dr. Laurencin was the Lillian T. Pratt Distinguished Professor and Chair of the Department of Orthopaedic Surgery at the University of Virginia. Dr. Laurencin was also designated a University Professor by the President of the University of Virginia. Prior to February 2003, Dr. Laurencin held various positions of increasing responsibility at Drexel University, including the Helen I. Moorehead Distinguished Professor of Chemical Engineering, Vice Chairman of the Department of Orthopaedic Surgery and Director of Shoulder Surgery, and at MCP-Hahnemann School of Medicine, where he served as Clinical Professor of Orthopaedic Surgery and Research Professor of Pharmacology and Physiology. Dr. Laurencin has a B.S.E. degree in chemical engineering from Princeton University and earned his medical degree from Harvard University Medical School. Dr. Laurencin also has a Ph.D. in biochemical engineering/biotechnology from the Massachusetts Institute of Technology.

Basic Compensation

Name Fiscal Year Total
Fallon, Kenneth --
Owusu-Akyaw, Sam 740,016
Burroughs, Mark 357,428
Wynalek, Robert 373,886
Honneffer, Robert 321,660
Galliker, Stephen --
Palmisano, Robert --
Shannon, James --
Laurencin, Cato --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Fallon, Kenneth 0 0
Owusu-Akyaw, Sam 285,000 125,350
Burroughs, Mark 0 0
Wynalek, Robert 0 0
Honneffer, Robert 0 0
Galliker, Stephen 0 0
Palmisano, Robert 0 0
Shannon, James 0 0
Laurencin, Cato 0 0

Insider Trading

Name Shares Traded Price
HEYMAN STEPHEN J 12,807 $3.21
HEYMAN STEPHEN J 400 $3.21
HONNEFFER ROBERT W 2,122 $0.00
WYNALEK ROBERT M 2,741 $0.00
WYNALEK ROBERT M 945 $3.20
HONNEFFER ROBERT W 732 $3.20
WYNALEK ROBERT M 362 $2.97
BURROUGHS MARK H 1,013 $0.00
HONNEFFER ROBERT W 388 $2.97
WYNALEK ROBERT M 1,050 $0.00
OWUSU AKYAW SAM 1,089 $2.97
HONNEFFER ROBERT W 1,125 $0.00
OWUSU AKYAW SAM 2,625 $0.00
BURROUGHS MARK H 420 $2.97
BURROUGHS MARK H 1,125 $0.00
HONNEFFER ROBERT W 388 $2.97
WYNALEK ROBERT M 1,125 $0.00
OWUSU AKYAW SAM 942 $2.97
HONNEFFER ROBERT W 1,125 $0.00
OWUSU AKYAW SAM 2,272 $0.00
BURROUGHS MARK H 467 $2.97
WYNALEK ROBERT M 388 $2.97
HONNEFFER ROBERT W 4,490 $4.55
OWUSU AKYAW SAM 16,580 $4.55
BURROUGHS MARK H 11,900 $0.00
» Full list on Insider Trading
view people for: